Repligen
RGEN
#2735
Rank
HK$50.12 B
Marketcap
HK$888.61
Share price
-1.53%
Change (1 day)
-7.49%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): HK$0.65 Billion

According to Repligen 's latest financial reports the company's current earnings are HK$0.73 Billion. , an increase over its 2024 earnings that were of -HK$49.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 HK$0.65 B-1430.84%
2024 -HK$49.39 Million-113.01%
2023 HK$0.37 B-78.01%
2022 HK$1.72 B33.37%
2021 HK$1.29 B131.52%
2020 HK$0.55 B101.31%
2019 HK$0.27 B25.93%
2018 HK$0.22 B105.61%
2017 HK$0.10 B-11.46%
2016 HK$0.12 B14.91%
2015 HK$0.10 B20.26%
2014 HK$87.65 M-51.49%
2013 HK$0.18 B90.98%
2012 HK$94.6 M
2010 HK$1.37 M-103.81%
2009 -HK$35.94 Million-223.84%
2008 HK$29.01 M
2006 -HK$19.5 Million229.64%
2005 -HK$5.92 Million-89.16%
2004 -HK$54.57 Million-16.86%
2003 -HK$65.64 Million88.72%
2002 -HK$34.78 Million-27.88%
2001 -HK$48.22 Million-1.74%
2000 -HK$49.08 Million85.93%
1999 -HK$26.4 Million159.16%
1998 -HK$10.19 Million85.71%
1997 -HK$5.49 Million-70.83%
1996 -HK$18.81 Million-72.41%
1995 -HK$68.16 Million-60.63%
1994 -HK$0.18 Billion45.39%
1993 -HK$0.12 Billion39.45%
1992 -HK$85.4 Million-32.3%
1991 -HK$0.13 Billion6.62%
1990 -HK$0.12 Billion1577.78%
1989 -HK$7.06 Million-57.14%
1988 -HK$16.46 Million-362.5%
1987 HK$6.26 M-130.77%
1986 -HK$20.37 Million136.36%
1985 -HK$8.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.96 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$58.14 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$86.02 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.18 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.86 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$3.64 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$6.25 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$0.96 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-HK$0.78 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA